Nasdaq
$3.28▲ 0.46%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $85.1MShares out 25.9M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
24- 2d agoAfter-hours26.10.23 06:208-KKey event#●●●#●●●
NEONC TECHNOLOGIES HOLDINGS, INC.Bullish
NeOnc Technologies reported early clinical improvement in the first patient treated with investigational NEO100 under its Compassionate Care program in Abu Dhabi and signed a Memorandum of Understanding (MoU) with the Abu Dhabi Department of Health to collaborate on CNS cancer research. Additionally, the company will be featured on the Fox Business Network's 'Health Uncensored with Dr. Drew' on October 25 to discuss its non-invasive brain tumor therapy approach.…more
$3.28+0.46%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.16Overnight26.10.16 10:333Ownership
NEONC TECHNOLOGIES HOLDINGS, INC.
Insider ALABEDIN ALI MOHAMMAD AHMAD MOHAMMAD of NEONC TECHNOLOGIES HOLDINGS, INC. has filed an SEC Form 3 to report their initial statement of beneficial ownership. This filing serves as a formal disclosure of equity holdings by key insiders.…more
$3.28+0.46%vs prev closeView filingShare - 10.15After-hours26.10.16 05:308-KKey event
NEONC TECHNOLOGIES HOLDINGS, INC.
NeOnc Technologies has appointed Ali Mohammad Ahmad Alabedin to its Board of Directors, succeeding the resigning director Steven L. Giannotta. Alabedin, a financial and governance expert formerly with First Abu Dhabi Bank, will support the company's clinical development and expansion efforts in Abu Dhabi.…more
$3.28+0.46%vs prev closeView filingShare
23 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 1d agoRegular26.10.24 02:01#●●●#●●●#●●●
NeOnc Shares Rally on Technical Breakout and Clinical Milestones
NeOnc has cleared key technical resistance levels amid growing anticipation for upcoming clinical and regulatory milestones. Investors should note that this report is a paid editorial and requires careful verification of fundamental progress.…more
$3.28+0.46%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 2d agoPre-market26.10.22 22:28
●●●●●●●● ●●●●● ●●●●●●
NeOnc Technologies will discuss its brain cancer research and recent collaborations in Abu Dhabi on Fox Business. This announcement is a paid editorial and lacks definitive clinical or financial data, warranting a neutral outlook.…more
$3.28+0.46%vs prev close - 2d agoPre-market26.10.22 21:00
●●●●●●●● ●●●●● ●●●●●●
NeOnc Technologies will be featured on a television program to discuss its investigational intranasal brain tumor therapy, NEO100. This appearance is promotional in nature and does not represent new clinical data or regulatory milestones.…more
$3.28+0.46%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report